Avid Bioservices Inc (CDMO)

[Thurly]

The most successful had been run outside the USA - India, Russian Federation, Georgia, Ukraine.
When I called Peregrine and asked about their quality control measures three-four years ago they said they monitored the foreign sites at least monthly according to the international standards I mentioned in my last post.

The ongoing trials (most are ISTs) are largely located in the United States.
Pancreatic has 15 USA sites, 4 Ukraine sites.
Rectal Adenocarcinoma is all USA
Castration Resistant Prostate Cancer is all USA
Her2-Neg Metastatic Breast Cancer is All USA
Liver Cancer is all USA
NSCLC with Pemetrexed is all USA

Two of these trials are expected to report out data by the end of the year.

The current PIIb trials in NSCLC are both split about 50/50 USA and exUS.